Aurobindo Pharma denies media reports on $5.5 billion Zentiva buyout
The clarification, filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, states that while the company routinely explores strategic opportunities such as acquisitions and partnerships to strengthen its long-term growth, no binding agreement or definitive decision has been taken by the Board of Directors in connection with the rumored Zentiva deal.
The company emphasized that the media reports are premature and speculative, and investors should not rely on such information. Aurobindo Pharma also assured that in case of any concrete development that warrants disclosure under SEBI regulations, it will promptly make an official announcement to the stock exchanges.
With this clarification, Aurobindo Pharma reiterated its commitment to maintaining full compliance with SEBI disclosure requirements and ensuring transparency for its stakeholders.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
9 hours ago
- Business Upturn
R Systems International to acquire 100% stake in Novigo Solutions for up to Rs 400 crore
R Systems International Limited, a global leader in digital product engineering, has announced an exciting move to acquire Novigo Solutions, a specialist in low-code/no-code (LCNC) development and intelligent automation services. This strategic acquisition brings together two powerhouses in digital engineering, creating a combined entity with annual revenue of around INR 20,600 million (~$240M) and INR 3,800M (~$45M) EBITDA. The combined platform will offer end-to-end engineering, deployment, and management of enterprise-scale AI agent fleets under a single, governed system. Novigo has been on a remarkable growth trajectory, delivering 44% revenue CAGR over the past three years, with a 25% EBITDA margin and strong free cash flow. The acquisition deal includes an upfront cash payment of INR 400 crore, with additional stock consideration tied to future performance. Importantly, this deal is expected to be EPS accretive for R Systems right from year one. By joining forces, R Systems and Novigo are well-positioned to meet the evolving demands of enterprises increasingly shifting IT budgets toward autonomous, compliance-ready AI workflows. The integration combines R Systems' OptimaAI Suite with Novigo's UiPath Diamond-tier automation expertise and Microsoft Copilot Centre of Excellence, creating a unique capability to design, orchestrate, and operate intelligent enterprises of the future. The acquisition also expands R Systems' presence in the fast-growing Middle East market and enhances delivery capabilities in Bangalore and Tier 2 cities like Mangalore. Novigo's leadership team will continue to be part of the combined platform, driving growth and innovation. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
11 hours ago
- Business Upturn
Hikal receives warning letter from US FDA for Jigani facility
By Aman Shukla Published on August 21, 2025, 17:52 IST Hikal Ltd., a leading pharmaceutical and chemical manufacturing company, has received a warning letter from the United States Food and Drug Administration (US FDA) concerning its manufacturing facility in Jigani, Bengaluru. The notification follows the US FDA inspection conducted from February 3rd to February 7th, 2025, which was previously communicated to investors on 8th February 2025 and 23rd May 2025. The company has stated that it is committed to working closely with the US FDA to address the issues raised and implement corrective actions promptly. Hikal emphasizes that quality and regulatory compliance remain a top priority, and it continues to uphold current Good Manufacturing Practices (cGMP) across all its manufacturing units. This development is an important update for stakeholders and investors, reflecting Hikal's transparent approach to regulatory compliance and its ongoing efforts to meet international quality standards. Hikal assures that it is taking all necessary measures to resolve the FDA concerns swiftly, reinforcing its commitment to high-quality pharmaceutical manufacturing and global regulatory adherence. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
13 hours ago
- Business Upturn
Intellect Design Arena's UK subsidiary to form JV with ITIXA in GIFT City, Gujarat
Intellect Design Arena Limited has announced that its UK subsidiary, Intellect Design Arena Limited, UK, has approved a Memorandum of Understanding (MOU) to establish a joint venture with UK-based ITIXA Limited, a group company of System Holdings Limited. The formal joint venture agreement will be signed soon. The new entity is planned to be set up in GIFT City, IFSC, Gujarat, and will focus on providing AI-enabled software solutions along with bookkeeping, accounting, payroll, HR, and other business support services to businesses in the United Kingdom. The services will also extend to accounting firms, regulators, other accounting software providers, and their clients. Over time, the JV may explore additional services and expand geographically, subject to mutual agreement. In terms of structure, Intellect Design Arena UK will hold a 50.1% stake, while ITIXA Limited will hold 49.9%, with equal representation on the Board of Directors. The companies confirmed that there is no relationship with promoters or group companies, and the arrangement is not a related-party transaction. The move is part of Intellect Design Arena's ongoing strategy to leverage technology and AI to offer smarter business solutions globally, while strengthening its presence in the UK market. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
